Katayoon Shayan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Katayoon Shayan has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Alexa L. Li
Viterbi Department of Ophthalmology, Shiley Eye Institute, University of California, San Diego, 9415 Campus Point Drive, La Jolla, CA, 92093, USA
1 shared publication Allison M. Han
Rady Children's Hospital Division of Pediatric and Adolescent Dermatology San Diego USA
1 shared publication- Angelina Labib
Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery and Miami Itch Center University of Miami Miller School of Medicine Miami Florida USA
1 shared publication - Caitlin A. Orner
Medical College of Wisconsin Department of Orthopaedic Surgery, Milwaukee, Wisconsin, USA
1 shared publication Caitlin E. Carter
Division of Pediatric Nephrology, Rady Children's Hospital San Diego, 3020 Children's Way, San Diego, CA, 92123, USA
1 shared publication- Claire E. Manhard
Department of Orthopedic Surgery, Rady Children's Hospital, San Diego, California, USA
1 shared publication
Latest Publications
- 19 July 2025
- Published by Wiley in Pediatric Dermatology
- Vol. 43 (1) , 121-124
Cutaneous Juvenile Xanthogranuloma With MRC1::PDGFRB Gene Fusion: A Case Report
Juvenile xanthogranulomas (JXGs) are benign solitary or multiple lesions that present as yellow‐red nodules on the skin or other organs, with histology demonstrating normolipidemic, non‐Langerhans cell histiocytosis. We present a case of a clinically atypical lesion shown to be of the JXG family of lesions following pathologic review. Next‐generation sequencing (NGS) analysis revealed a MRC1::PDGFRB gene fusion. This is the third report of the MRC1::PDGFRB gene fusion identified in JXG, and the first case of an isolated cutaneous lesion, which highlights the spectrum of the MRC1::PDGFRB gene fusion in JXG.
- 19 July 2025
- Published by Wiley in Pediatric Dermatology
- Vol. 43 (1) , 121-124
Cutaneous Juvenile Xanthogranuloma With MRC1::PDGFRB Gene Fusion: A Case Report
Juvenile xanthogranulomas (JXGs) are benign solitary or multiple lesions that present as yellow‐red nodules on the skin or other organs, with histology demonstrating normolipidemic, non‐Langerhans cell histiocytosis. We present a case of a clinically atypical lesion shown to be of the JXG family of lesions following pathologic review. Next‐generation sequencing (NGS) analysis revealed a MRC1::PDGFRB gene fusion. This is the third report of the MRC1::PDGFRB gene fusion identified in JXG, and the first case of an isolated cutaneous lesion, which highlights the spectrum of the MRC1::PDGFRB gene fusion in JXG.
- 28 January 2025
- Published by Springer Nature in Pediatric Nephrology
- Vol. 40 (7) , 2375-2382
Follow-up biopsies with microvascular inflammation and persistent donor specific antibodies identify ongoing rejection in pediatric kidney transplant recipients
Background Inadequate treatment of acute rejection (AR) in pediatric kidney transplant recipients (KTR) can contribute to early allograft failure. Serum creatinine is an insensitive marker of allograft function, especially in the pediatric population, and may not detect ongoing rejection after treatment. We evaluated the utility of follow-up biopsies to detect persistent inflammation and future episodes of rejection. Methods We performed a single-center retrospective review to identify pediatric KTR with biopsy-proven rejection and a subsequent follow-up biopsy, noting type of AR, Banff scores, serum creatinine, and presence of donor specific antibodies (DSA). Outcomes included resolution of AR, change in eGFR, DSA, persistent microvascular inflammation (MVI) and future episodes of AR. Results Twelve cases of cellular (TCMR), 9 antibody-mediated (AMR), and 8 mixed cases of AR were identified among 23 KTR. Resolution was noted in 75% with TCMR, significantly higher than AMR (22%) or mixed rejection (13%), p < 0.01. Those without resolution of AR on follow-up biopsy were more likely to have ongoing episodes of AR or graft loss (p = 0.02). Persistence of DSA and MVI was associated with lack of AR resolution (p = 0.01 and p = 0.001, respectively). Those with persistent MVI on follow-up biopsy had higher probability of future AR events or graft loss, p = 0.003. Conclusion Follow-up biopsies to assess response to AR treatment revealed that most cases of TCMR were successfully treated but that AMR and mixed rejection portend a component of chronicity and more complicated course. Identification of persistent subclinical inflammation predicts future rejection episodes, has adverse effects on graft longevity, and can inform the need for additional treatment. We advocate for implementation of a follow-up biopsy protocol and future study of non-invasive biomarkers paired with protocol biopsies. Graphical abstract A higher resolution version of the Graphical abstract is available as Supplementary information
- 28 January 2025
- Published by Springer Nature in Pediatric Nephrology
- Vol. 40 (7) , 2375-2382
Follow-up biopsies with microvascular inflammation and persistent donor specific antibodies identify ongoing rejection in pediatric kidney transplant recipients
Background Inadequate treatment of acute rejection (AR) in pediatric kidney transplant recipients (KTR) can contribute to early allograft failure. Serum creatinine is an insensitive marker of allograft function, especially in the pediatric population, and may not detect ongoing rejection after treatment. We evaluated the utility of follow-up biopsies to detect persistent inflammation and future episodes of rejection. Methods We performed a single-center retrospective review to identify pediatric KTR with biopsy-proven rejection and a subsequent follow-up biopsy, noting type of AR, Banff scores, serum creatinine, and presence of donor specific antibodies (DSA). Outcomes included resolution of AR, change in eGFR, DSA, persistent microvascular inflammation (MVI) and future episodes of AR. Results Twelve cases of cellular (TCMR), 9 antibody-mediated (AMR), and 8 mixed cases of AR were identified among 23 KTR. Resolution was noted in 75% with TCMR, significantly higher than AMR (22%) or mixed rejection (13%), p < 0.01. Those without resolution of AR on follow-up biopsy were more likely to have ongoing episodes of AR or graft loss (p = 0.02). Persistence of DSA and MVI was associated with lack of AR resolution (p = 0.01 and p = 0.001, respectively). Those with persistent MVI on follow-up biopsy had higher probability of future AR events or graft loss, p = 0.003. Conclusion Follow-up biopsies to assess response to AR treatment revealed that most cases of TCMR were successfully treated but that AMR and mixed rejection portend a component of chronicity and more complicated course. Identification of persistent subclinical inflammation predicts future rejection episodes, has adverse effects on graft longevity, and can inform the need for additional treatment. We advocate for implementation of a follow-up biopsy protocol and future study of non-invasive biomarkers paired with protocol biopsies. Graphical abstract A higher resolution version of the Graphical abstract is available as Supplementary information
- 1 July 2023
- Published by Wolters Kluwer Health in JBJS Case Connector
- Vol. 13 (3)
Intermediate Outcomes of Shoulder Synovial Chondromatosis in an Adolescent Boy
Case: Synovial chondromatosis is a rare condition affecting synovial joints. It occurs uncommonly in the shoulder and is rare in the pediatric population. We present a case of a 13-year-old male patient with shoulder pain who was diagnosed with synovial chondromatosis and a posterior labral tear. He was treated with arthroscopic loose body removal, synovectomy, and posterior labral repair and recovered well from the surgery. Four years after the surgery, he developed pain in the same shoulder, but the cause of the pain was not investigated per the patient's decision. Conclusion: Synovial chondromatosis should be considered in pediatric patients presenting with shoulder pain and loss of function with potential for recurrence.
- 1 July 2023
- Published by Wolters Kluwer Health in JBJS Case Connector
- Vol. 13 (3)
Intermediate Outcomes of Shoulder Synovial Chondromatosis in an Adolescent Boy
Case: Synovial chondromatosis is a rare condition affecting synovial joints. It occurs uncommonly in the shoulder and is rare in the pediatric population. We present a case of a 13-year-old male patient with shoulder pain who was diagnosed with synovial chondromatosis and a posterior labral tear. He was treated with arthroscopic loose body removal, synovectomy, and posterior labral repair and recovered well from the surgery. Four years after the surgery, he developed pain in the same shoulder, but the cause of the pain was not investigated per the patient's decision. Conclusion: Synovial chondromatosis should be considered in pediatric patients presenting with shoulder pain and loss of function with potential for recurrence.
- Open Access
- 15 December 2022
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 29, 101781
Dent disease presenting with nyctalopia and electroretinographic correlates of vitamin A deficiency
- 15 December 2022
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 29, 101781
Open AccessDent disease presenting with nyctalopia and electroretinographic correlates of vitamin A deficiency
- 1 December 2009
- Published by Wiley in Neuropathology
- Vol. 29 (6) , 744-747
A nine-year-old boy with temporal lobe enhancing mass
- 1 December 2009
- Published by Wiley in Neuropathology
- Vol. 29 (6) , 744-747
A nine-year-old boy with temporal lobe enhancing mass